The Week in Review: Covance Inc. Advances on its Shanghai Lab

Trade Wars Go Both Ways August 25, 2007 – Last week, China returned a shipment of substandard pacemakers from St. Jude Medical, igniting fears of a public relations war; Covance is scheduled to open its Shanghai laboratory; big pharma in general and Novartis in particular is choosing to build new facilities in China rather than India; Beijing Med-Pharm raised $31 million so it can continue its acquisitive ways; China Shenghuo reported much improved Q2 results; Optimer Pharma entered talks with C&O Pharma about a collaboration; and China will allow its citizens the right to invest in Hong Kong-listed stocks. More details...

MORE ON THIS TOPIC